Biotech Eiger Can Take Sentynl's Improved Drug Bid In Ch. 11
By Alex Wittenberg · April 3, 2024, 8:00 PM EDT
Eiger BioPharmaceuticals Inc. received approval Wednesday to select a $30 million base offer for its Zokinvy drug and use cash collateral after a Texas bankruptcy judge dismissed objections to the relief,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login